The journey to AAPS 2020: a reflection from strategic planning to PharmSci 360

• Joseph W. Polli,
• Christopher R. McCurdy,
• Dale Eric Wurster,
• Binodh S. DeSilva,
• Annette Bak,
• Reina Bendayan,
• Bernd Meibohm,
• Allen C. Templeton,
• William Weiser,
• for the AAPS Leadership

Affiliations

Joseph W. Polli

GlaxoSmithKline, Mechanistic Safety and Drug Disposition

Christopher R. McCurdy

Department of Medicinal Chemistry, College of Pharmacy, University of Florida

Dale Eric Wurster

Division of Pharmaceutics and Translational Therapeutics, The University of Iowa, College of Pharmacy

Binodh S. DeSilva

Bristol-Myers Squibb One Squibb Drive

Annette Bak

Advanced Drug Delivery, Pharmaceutical Sciences, IMED Biotech Unit

Reina Bendayan

Department of Pharmaceutical Sciences Leslie Dan Faculty of Pharmacy, University of Toronto

Bernd Meibohm

The University of Tennessee Health Science Center, College of Pharmacy

Allen C. Templeton

Merck and Co Inc, RY119-A100

William Weiser

for the AAPS Leadership